Key facts
- This page summarizes Samir M. Deshpande's Form 4 filing for HUMANA INC (HUM).
- 4 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 23 Feb 2024, 13:21.
Samir M. Deshpande - 21 Feb 2024 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- Chief Information Officer
- Issuer ticker
- HUM
- Reported as of
- 21 Feb 2024
- Net transaction value
- -$476,669
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2024, 13:21:28 UTC
- Prior SEC filing
- 19 Dec 2023
- Next SEC filing
- 17 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- Samir M. Deshpande
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Samir M. Deshpande filed Form 4 for HUMANA INC (HUM) on 23 Feb 2024.
Change
- Previous filing in this sequence was filed on 19 Dec 2023.
- Current net transaction value: -$476,669.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
transaction
Humana Common
Options Exercise
- Transaction value
- $0
- Shares
- +3,770
- Change %
- +38%
- Price
- $0.000000
- Shares after
- 13,698
- Date
- 22 Feb 2024
- Ownership
- Direct
- Footnotes
- F9
HUM
transaction
Humana Common
Tax liability
- Transaction value
- $476,669
- Shares
- -1,302
- Change %
- -9.5%
- Price
- $366.10
- Shares after
- 12,396
- Date
- 22 Feb 2024
- Ownership
- Direct
- Footnotes
- F10
HUM
transaction
Humana Common
Award
- Transaction value
- $0
- Shares
- +1,464
- Change %
- +12%
- Price
- $0.000000
- Shares after
- 13,860
- Date
- 21 Feb 2024
- Ownership
- Direct
- Footnotes
- F11, F12
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
transaction
Derivative
Options
Award
- Transaction value
- $0
- Shares
- +5,652
- Change %
- Price
- $0.000000
- Shares after
- 5,652
- Date
- 21 Feb 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 5,652
- Exercise price
- $367.21
- Footnotes
- F5
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,730
- Date
- 21 Feb 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 5,730
- Exercise price
- $350.79
- Footnotes
- F1
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,327
- Date
- 21 Feb 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 4,327
- Exercise price
- $376.61
- Footnotes
- F2
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,836
- Date
- 21 Feb 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,836
- Exercise price
- $425.06
- Footnotes
- F3
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,878
- Date
- 21 Feb 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,878
- Exercise price
- $510.24
- Footnotes
- F4
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 353
- Date
- 21 Feb 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 353
- Exercise price
- Footnotes
- F6, F7
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 670
- Date
- 21 Feb 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 670
- Exercise price
- Footnotes
- F6, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 12 footnotes
Footnote F1
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
Footnote F2
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
Footnote F3
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
Footnote F4
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
Footnote F5
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
Footnote F6
Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Footnote F7
Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
Footnote F8
Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
Footnote F9
Includes Performance Stock Units that are not required to be reported until vest.
Footnote F10
Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/22/24.
Footnote F11
Restricted stock units granted to reporting person on 2/21/24.
Footnote F12
Includes 1,464 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.